Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 010012
Company: LILLY
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
SANDRIL RESERPINE 2.5MG/ML INJECTABLE;INJECTION Discontinued None No No
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
07/20/1983 SUPPL-6 Labeling

Label is not available on this site.

10/22/1981 SUPPL-4 Manufacturing (CMC)

Label is not available on this site.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English